Objectives: Occurrence of post-intubation laryngotracheal stenosis (LTS) with respect to COVID-19 status.
Design: Retrospective cross-sectional inpatient database.
Setting: Eleven Midwest academic and community hospitals, United States.
Almost half of Americans 65 years of age and older take statins, which are highly effective in lowering low-density lipoprotein cholesterol, preventing atherosclerotic cardiovascular disease (ASCVD), and reducing all-cause mortality. Unfortunately, ∼50% of patients prescribed statins do not obtain these critical benefits because they discontinue use within one year of treatment initiation. Therefore, statin discontinuation has been identified as a major public health concern due to the increased morbidity, mortality, and healthcare costs associated with ASCVD.
View Article and Find Full Text PDFAMIA Jt Summits Transl Sci Proc
May 2020
Simvastatin is a commonly used medication for lipid management and cardiovascular disease, however, the risk of adverse events (AEs) with its use increases via drug-drug interaction (DDI) exposures. Patients were extracted if initially diagnosed with cardiovascular disease and newly initiated simvastatin therapy. The cohort was divided into a DDI-exposed group and a non-DDI exposed group.
View Article and Find Full Text PDF